How Politics Became Every Hospital’s Brand Risk
When governments fall short on public health, hospitals inherit the fallout. Those with the strongest…
How Politics Became Every Hospital’s Brand Risk
When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it. The post How Politics Became Every Hospital’s Brand Risk appeared first on MedCity News.
What Healthcare Boards Need to Know Post-Midterms
A new Congress and H.R. 1’s Medicaid provisions could reshape healthcare policy and provider operations in 2027
Midterms Put Medicaid and Rural Healthcare Back in Focus
Rural hospitals operate on thin margins, and changes to Medicaid funding could affect access to preventive, behavioral, and chronic care
Rules Governing Human Oversight of AI in Health Care Could Shape Public Trust — The Monitor
New regulations and guidelines for the use of AI in health care have sought to answer questions about human oversight and accountability. Separately, a new HHS initiative aims to expand research into potential vaccine injuries, but some medical organizations have questioned how the efforts may be perceived.
Health Data Access Advances, but Privacy and Security Must Keep Pace, Panelists Say
Panelists emphasized that patients need their information available when they seek care, while also understanding how it is being used and protected
Medicaid Work Rules Don’t Apply to Native Americans. They Could Still Lose Coverage.
CHEROKEE, N.C. — Two months before the deadline to implement new Medicaid work requirements, states had yet to receive detailed guidance from federal health officials on how to exclude Native Americans from those rules, leading to a patchwork of eligibility checks that pose challenges for qualified enrollees trying to keep their health insurance. President Donald…
Fed Up With the Healthcare Industry, This Red State Capped Insulin Prices for Patients
HILLSBORO, N.D. — The Kritzberger family has farmed in the Red River Valley for more than a century. They once had livestock. Now they grow sugar beets, soybeans, and grains. Like many farmers, they labor to balance the books. “We’re in an incredible amount of debt,” Ang Kritzberger said as she walked the farm on…
340B’s Next Chapter Will Be Won (or Lost) on Data. Most Organizations Aren’t Ready.
By ADAM COHEN The debate over the 340B Drug Pricing Program is complicated. However, beyond the arguments over rebates, contract pharmacies, and program intent sits a simpler reality that every stakeholder should plan around. Whatever form 340B takes next, the value an organization captures will depend on its ability to document and justify every discounted…
62 Organizations Call on Congress to Advance 4 Medicare Reforms
The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care. The post 62 Organizations Call on Congress to Advance 4 Medicare Reforms appeared first on MedCity News.
Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials
Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal. The post Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials appeared first on MedCity News.
